The results of the Oncotype DX Breast Cancer Assay (for invasive Breast cancer) are provided as a breast Cancer Recurrence Score result (a number between 0 to 100). This number corresponds to a specific likelihood that a woman’s breast cancer will spread to another area of her body within 10 years of her initial diagnosis. The lower the score is, the lower the chances are that the woman’s breast cancer will come back. The higher the score is, the greater the chances that the breast cancer will come back.

Dr. Hope Rugo discusses how the Recurrence Score result of the Oncotype DX Breast Cancer Assay could influence treatment decisions, especially in the intermediate Recurrence Score group. She confirms, from her experience, that the Oncotype DX Breast Cancer Assay Recurrence Score result reduces physicians’ and patients’ anxiety regarding their optimal treatment decisions.

This programme has been supported by sponsorship from Genomic Health.